← Open Payments lookup

VICTOR CHEANG: Open Payments

NPI 1528240926 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,762 in 76 payments from 9 companies in 2025. Trend: 2023 $3,251 · 2024 $3,157 · 2025 $3,762

Food & beverage: $3,762
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.15$732
Janssen Pharmaceuticals, Inc9$628
Alkermes, Inc.15$585
Teva Pharmaceuticals USA, Inc.7$499
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$453
Otsuka America Pharmaceutical, Inc.14$441
Neurocrine BioSciences, Inc.2$248
Vanda Pharmaceuticals Inc.2$158
ABBVIE INC.1$17

Products named: COBENFY, INVEGA SUSTENNA, ARISTADA, CAPLYTA, UZEDY, INGREZZA, AUSTEDO XR, REXULTI.

Industry payments across CA — which companies pay providers there.